logo-loader
viewOriginClear

OriginClear has 'slate of acquisitions' lined up for 2019

OriginClear Inc (OTCQB:OCLN) CEO Riggs Eckelberry tells Proactive Investors the water treatment company is focused on its 'slate of acquisitions' lined up for next year.

Eckelberry says the company licenses its Electro Water Separation technology using Advanced Oxidation to water treatment equipment manufacturers, and is growing the business by acquiring water treatment companies.

Quick facts: OriginClear

Price: - -

OTCMKTS:OCLN
Market: OTCMKTS
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn reveals its drug inhibits colon carcinoma metastases...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive its flagship drug leronlimab inhibited a human colon carcinoma cell line metastases to liver and lung in a well-accepted mouse model. Pourhassan says the company plans to file an IND for expanded access for a Phase 2 basket...

15 hours, 51 minutes ago

2 min read